HIV Malignancy Specimens for Research at No Charge
Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year …
Through this Funding Opportunity Announcement (FOA) RFA-CA-22-051, the National Cancer Institute (NCI) solicits applications from institutions/organizations to participate as Clinical Sites for the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network. …
With the support of the Equity Council, NCI launched EIAP in late 2021 to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. The cancer research enterprise …
(From the CFAR Adelante RFA: https://cfar-adelante.org/wp-content/uploads/2022/08/Adelante.RFA-CohortV_FINAL-081522.pdf) As confirmed by the National Ending the HIV Epidemic in the U.S. (EHE) Initiative, there has been adearth of culturally responsive research specific to …
The NIH Office of AIDS Research (OAR) is working with All of Us Research Program to advance precision medicine All of Us to award up to $2 million in FY22 …
The purpose of this Notice is to encourage current funded NCI extramural investigators to apply for administrative supplements to support mentored cancer research career development of early-stage low- and middle-income …
The American Association for Cancer Research (AACR)-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship provides a two-year grant of $120,000 to support the salary and benefits of a postdoctoral or clinical research …
NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement …
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trials Not Allowed) Attention Biorepositories and Biospecimen Science Programs! The earliest submission date for this National Cancer Institute Funding Opportunity …